Zhang Ling, Ma Chao, Yin Xin, Zhang Fenglian, Fang Xiuyan, Zhang Chen, Shang Lei, Ma Li
Department of General Medicine, Heze Hospital Affiliated to Shandong First Medical University, Shandong, 274000, China.
Department of General Medicine, Shandong Provincial Hospital Heze Branch, Shandong, 274000, China.
Sci Rep. 2025 May 7;15(1):15880. doi: 10.1038/s41598-025-00448-x.
Thyroid dysfunction is associated with bone health, but the relationship with osteopenia remains unclear. This study aimed to investigate the association between thyroid function and osteopenia/osteoporosis across different age groups. The study included 4508 men and 1438 women who underwent health check-ups between January 2021 and December 2023. Bone mineral density (BMD) was measured using dual energy X-ray absorptiometry. Logistic regression analysis was employed to evaluate the association between thyroid function and the risk of osteopenia/osteoporosis. The results showed that in postmenopausal women, both hyperthyroidism and age increased the risk of osteopenia and osteoporosis, while body mass index (BMI) was negatively correlated with both conditions. In men over 50, hyperthyroidism and age were also linked to a higher risk of osteoporosis. Among postmenopausal women, higher thyroid-stimulating hormone (TSH) levels were negatively associated with osteopenia risk. In men aged 50 and above, free thyroxine (fT4) levels were inversely related to osteopenia and osteoporosis risk. In men under 50, fT4 levels were negatively linked to the risk of low bone mass. These findings suggest that TSH and fT4 levels may influence bone health, with these effects varying by age and sex. Further studies are needed to confirm these findings and explore potential mechanisms.
甲状腺功能障碍与骨骼健康相关,但与骨质减少的关系仍不明确。本研究旨在调查不同年龄组甲状腺功能与骨质减少/骨质疏松之间的关联。该研究纳入了2021年1月至2023年12月期间接受健康检查的4508名男性和1438名女性。使用双能X线吸收法测量骨密度。采用逻辑回归分析评估甲状腺功能与骨质减少/骨质疏松风险之间的关联。结果显示,在绝经后女性中,甲状腺功能亢进和年龄均增加了骨质减少和骨质疏松的风险,而体重指数(BMI)与这两种情况均呈负相关。在50岁以上的男性中,甲状腺功能亢进和年龄也与较高的骨质疏松风险相关。在绝经后女性中,较高的促甲状腺激素(TSH)水平与骨质减少风险呈负相关。在50岁及以上的男性中,游离甲状腺素(fT4)水平与骨质减少和骨质疏松风险呈负相关。在50岁以下的男性中,fT4水平与低骨量风险呈负相关。这些发现表明,TSH和fT4水平可能影响骨骼健康,且这些影响因年龄和性别而异。需要进一步研究来证实这些发现并探索潜在机制。